Tissue array analysis of expression microarray candidates identifies markers associated with tumor grade and outcome in serous epithelial ovarian cancer. - Wikidata - awgldk - TriplyDB

Tissue array analysis of expression microarray candidates identifies markers associated with tumor grade and outcome in serous epithelial ovarian cancer.

Tissue array analysis of expression microarray candidates identifies markers associated with tumor grade and outcome in serous epithelial ovarian cancer.

http://www.wikidata.org/entity/Q38314637

about

Impairment of glioma stem cell survival and growth by a novel inhibitor for Survivin-Ran protein complex Transforming growth factor-beta1, transforming growth factor-beta2, and transforming growth factor-beta3 enhance ovarian cancer metastatic potential by inducing a Smad3-dependent epithelial-to-mesenchymal transition A survivin-ran complex regulates spindle formation in tumor cells RAN nucleo-cytoplasmic transport and mitotic spindle assembly partners XPO7 and TPX2 are new prognostic biomarkers in serous epithelial ovarian cancer RAN GTPase is an effector of the invasive/metastatic phenotype induced by osteopontin Cyclin-dependent kinase-associated proteins Cks1 and Cks2 are essential during early embryogenesis and for cell cycle progression in somatic cells Activation of the Ran GTPase is subject to growth factor regulation and can give rise to cellular transformation.Immunohistochemical profiling of benign, low malignant potential and low grade serous epithelial ovarian tumors.Cdc20: a potential novel therapeutic target for cancer treatment Cdc20 and securin overexpression predict short-term breast cancer survival.Mitotic chromosomal instability and cancer: mouse modelling of the human disease.Cellular apoptosis susceptibility (CSE1L/CAS) protein in cancer metastasis and chemotherapeutic drug-induced apoptosis Essential role of the small GTPase Ran in postnatal pancreatic islet development.An essential role for Ran GTPase in epithelial ovarian cancer cell survival.Pathogenesis of serous, extra-uterine Müllerian epithelial cancer and therapeutic implications Screening of feature genes of the ovarian cancer epithelia with DNA microarray Targeting Cell Cycle Proteins in Breast Cancer Cells with siRNA by Using Lipid-Substituted Polyethylenimines.Microenvironment and pathogenesis of epithelial ovarian cancer Aberrant expression of Cks1 and Cks2 contributes to prostate tumorigenesis by promoting proliferation and inhibiting programmed cell death.Differentially Expressed Genes and Signature Pathways of Human Prostate Cancer.Increased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progression.Identification of differentially expressed genes according to chemosensitivity in advanced ovarian serous adenocarcinomas: expression of GRIA2 predicts better survival.Expression of Stem Cell Markers in Preinvasive Tubal Lesions of Ovarian Carcinoma.CSE1L, a novel microvesicle membrane protein, mediates Ras-triggered microvesicle generation and metastasis of tumor cells.Correlations between cytoplasmic CSE1L in neoplastic colorectal glands and depth of tumor penetration and cancer stage.Identification of Cathepsin K in the Peritoneal Metastasis of Ovarian Carcinoma Using In-silico, Gene Expression Analysis Protein profiling of ovarian cancers by immunohistochemistry to identify potential target pathways.An endogenous aryl hydrocarbon receptor ligand inhibits proliferation and migration of human ovarian cancer cells.Cks1 enhances transcription efficiency at the GAL1 locus by linking the Paf1 complex to the 19S proteasome Predictive and prognostic protein biomarkers in epithelial ovarian cancer: recommendation for future studies.Cks1: Structure, Emerging Roles and Implications in Multiple Cancers Cell division cycle 20 overexpression predicts poor prognosis for patients with lung adenocarcinoma.A comprehensive analysis of CDC20 overexpression in common malignant tumors from multiple organs: its correlation with tumor grade and stage.CAS (CSE1L) signaling pathway in tumor progression and its potential as a biomarker and target for targeted therapy.Characterization of a novel activated Ran GTPase mutant and its ability to induce cellular transformation.RanGTPase: A Key Regulator of Nucleocytoplasmic Trafficking Expression and role of the angiotensin II AT2 receptor in human prostate tissue: in search of a new therapeutic option for prostate cancer.High CDC20 expression is associated with poor prognosis in oral squamous cell carcinoma.Overexpression of CDC28 protein kinase regulatory subunit 1B confers an independent prognostic factor in nasopharyngeal carcinoma.Regulatory network involving miRNAs and genes in serous ovarian carcinoma.

P2860

Q24306474-BBDF72CC-64D8-4C43-A2E8-2431330EA696 Q24316645-E56B413C-BAC7-41D0-90BB-3FFE5FD988E8 Q24336928-C495ADCE-3EB1-459A-B182-40D118E11861 Q27316858-6E370653-6E7D-4501-B5BD-52610CB617F8 Q28568239-A4186211-BE9E-43AC-92B2-3CE23FBA475C Q28585746-9084342A-E779-470D-A2B1-A4B35DE30836 Q30433146-BD2F712A-49AA-4727-83AB-4E3305EB7802 Q33387074-1FF1EF9D-6A56-4ED2-A8C0-28C5CA5BE7FF Q33584460-118D97BF-4D01-48FE-9B8B-557A39A99CDF Q33750165-AF9857C9-D982-4FA7-839C-CBB0CF3DFCBB Q33926467-45345548-7E54-4036-BFD8-42D83080CDA5 Q34079161-58D8F1A9-A658-47CA-B3E7-29B128894C94 Q34082935-BA0F5D2A-292D-447E-92E3-3F062DFD49A3 Q34243626-3B46D086-F18B-4A0E-B9C5-04F556065437 Q34501822-A34C5EB8-8F5A-41F1-BB75-6BC06108B65D Q34759643-D39DE787-58AE-468D-964C-853064C31412 Q35087452-C8EFE595-E39A-48D1-AB80-12B89B02DD9C Q35419057-11DEF598-3849-4C92-A358-D4113FFA26F6 Q35685819-805F2094-EB9A-4626-A05E-D558C934BC62 Q35873154-E093AE1F-E461-4EC7-BA9A-DE0738E22D77 Q35953489-872B9901-2A93-408C-987F-8F98012F0342 Q36075250-807F2555-5BCF-43D4-A442-30D58AFDA546 Q36172983-AAF7A320-1DBD-43CA-9315-46891A853DAD Q36465278-E802374C-639A-4C6B-A326-A469A7376AD1 Q36588598-571AC249-03FC-443D-8B9F-A9D42624BB36 Q36792370-B13460B4-BD74-499A-9909-272AA6DB89FD Q36928958-23D2171F-6E70-45C0-B908-C67E9370FAB7 Q37194722-4BED3F11-1F5F-437B-A1C8-791E7C10C5EB Q37264100-90E78592-A33B-4FEF-9CD1-8D921B9E233B Q37328373-DAA8726A-83A4-4A28-AA1D-707E74D9B0F8 Q37595393-80C8AE59-42AD-4325-AE22-E149F7DAA3E1 Q38710141-4969BA0D-0530-4367-9EAF-2357939FEB04 Q38846085-9EA31053-70E7-4FEB-9786-A84493CED621 Q38946743-B6BE71B3-9C10-41AE-B3EB-F5A3BC4FBB00 Q39334910-8B195899-A213-46A2-B527-65272C31A243 Q39642947-0528717A-4850-44AE-883E-040B4028E281 Q43880703-22CD8AE7-6DD5-4B22-960B-64F4B2C0E3C7 Q44010823-5EE77F4D-8CFB-4FDB-A15E-7E0A06E2FEFC Q44416846-ABC298BB-D1E0-4AB7-B949-28C93DCE80A7 Q45874094-80A2EB90-6115-4FC7-B334-B159B23B638C

P2860

Tissue array analysis of expression microarray candidates identifies markers associated with tumor grade and outcome in serous epithelial ovarian cancer.

http://www.wikidata.org/entity/Q38314637

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Tissue array analysis of expre ...... ous epithelial ovarian cancer.

@en

type

label

Tissue array analysis of expre ...... ous epithelial ovarian cancer.

@en

prefLabel

Tissue array analysis of expre ...... ous epithelial ovarian cancer.

@en

P1433

Q38314637-2A99AA90-91FA-47AF-8B61-65B1D17949C0

P1476

Q38314637-F5D3306E-04D5-4B92-8EB0-AC736D089071

P2093

Q38314637-18759B64-452F-42C5-B6AE-5B1514E00D28

Q38314637-34D73286-FC93-4221-B080-464897391B25

Q38314637-4AE19E27-C17E-4B41-B515-72BCA68F2CA0

Q38314637-54F36519-A7F6-4176-9466-0FB6DC62503D

Q38314637-6362A61E-4C1F-4533-B82F-25D9764686CB

Q38314637-716A3A1B-6B86-4F66-99C4-9B5CE8AAB285

Q38314637-7DC0E101-A0EC-44BE-8E9E-3B731D701FF3

Q38314637-7DF0D4FC-0BF4-4898-A2C5-31B4BFB17DE3

P2860

Q38314637-D35020C0-1B17-434B-86C5-5F07312AC6FF

Q38314637-D410C04A-A225-45DD-9BDD-6CD19870A3A2

P304

Q38314637-636C2820-F759-494F-AE3D-6F01E122660A

P31

Q38314637-76D1D4E7-FB34-4298-84A7-CE644717F725

P356

Q38314637-1CD21150-CAF7-4D9B-AD75-4FC5BEE38652

P433

Q38314637-ACD390F0-D1A4-47BA-BC2C-6258BD13F30C

P478

Q38314637-5EEC3B70-244D-4D15-B23C-ECA863C70FF2

P577

Q38314637-C76978B0-3FCA-4E22-89C1-14B5501786FC

P5875

Q38314637-D3284363-67D5-4BB7-8937-24A8BC982F4A

P698

Q38314637-E1D1FC13-1E73-41A2-8C74-03F16440DBC4

P921

Q38314637-59C390F4-25A3-435D-92BF-BC2B042FE329

P356

P1433

International Journal of Cancer

P1476

Tissue array analysis of expre ...... ous epithelial ovarian cancer.

@en

P2093

Abdelali Filali-Mouhim

http://www.w3.org/2001/XMLSchema#string

Anne-Marie Mes-Masson

http://www.w3.org/2001/XMLSchema#string

Christian Lussier

http://www.w3.org/2001/XMLSchema#string

Cécile Le Page

http://www.w3.org/2001/XMLSchema#string

Diane M Provencher

http://www.w3.org/2001/XMLSchema#string

Marie-Claude Guyot

http://www.w3.org/2001/XMLSchema#string

Patricia N Tonin

http://www.w3.org/2001/XMLSchema#string

Véronique Ouellet

http://www.w3.org/2001/XMLSchema#string

P2860

Comparison of c-met expression in ovarian epithelial tumors and normal epithelia of the female reproductive tract by quantitative laser scan microscopy.

Hepatocyte growth factor modulates motility and invasiveness of ovarian carcinomas via ras mediated pathway.

P304

599-607

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IJC.21902

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

119

http://www.w3.org/2001/XMLSchema#string

P577

2006-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7207844

http://www.w3.org/2001/XMLSchema#string

P698

16572426

http://www.w3.org/2001/XMLSchema#string

P921